Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Mesa Laboratories (MLAB) EBITDA (2016 - 2025)

Mesa Laboratories' EBITDA history spans 16 years, with the latest figure at $8.0 million for Q4 2025.

  • For Q4 2025, EBITDA rose 38.0% year-over-year to $8.0 million; the TTM value through Dec 2025 reached $17.2 million, up 106.72%, while the annual FY2025 figure was $16.3 million, 106.0% up from the prior year.
  • EBITDA for Q4 2025 was $8.0 million at Mesa Laboratories, up from $4.7 million in the prior quarter.
  • Across five years, EBITDA topped out at $8.0 million in Q4 2025 and bottomed at -$271.3 million in Q1 2024.
  • The 5-year median for EBITDA is $3.1 million (2021), against an average of -$11.8 million.
  • The largest annual shift saw EBITDA tumbled 11518.18% in 2021 before it soared 8725.37% in 2024.
  • A 5-year view of EBITDA shows it stood at -$2.5 million in 2021, then skyrocketed by 235.43% to $3.4 million in 2022, then tumbled by 101.97% to -$67000.0 in 2023, then skyrocketed by 8725.37% to $5.8 million in 2024, then soared by 38.0% to $8.0 million in 2025.
  • Per Business Quant, the three most recent readings for MLAB's EBITDA are $8.0 million (Q4 2025), $4.7 million (Q3 2025), and $3.1 million (Q2 2025).